Doximity (NASDAQ:DOCS) Price Target Raised to $75.00 at Barclays

Doximity (NASDAQ:DOCS) had its target price hoisted by Barclays from $52.00 to $75.00 in a research report report published on Monday,Benzinga reports. Barclays currently has an overweight rating on the stock.

Other equities analysts have also recently issued research reports about the company. Bank of America boosted their price objective on Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Raymond James restated an “outperform” rating and issued a $65.00 target price (up from $37.00) on shares of Doximity in a research note on Friday, November 8th. Robert W. Baird lifted their price target on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Finally, Wells Fargo & Company raised Doximity from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $19.00 to $41.00 in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $48.14.

Doximity Stock Down 8.9 %

NASDAQ DOCS opened at $52.88 on Monday. The company has a fifty day moving average of $42.48 and a two-hundred day moving average of $33.68. The firm has a market capitalization of $9.82 billion, a price-to-earnings ratio of 60.78, a PEG ratio of 5.08 and a beta of 1.30. Doximity has a 52 week low of $22.96 and a 52 week high of $61.75.

Institutional Investors Weigh In On Doximity

A number of institutional investors have recently added to or reduced their stakes in DOCS. MetLife Investment Management LLC lifted its position in shares of Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after buying an additional 363 shares during the last quarter. FMR LLC raised its stake in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after acquiring an additional 1,598,602 shares in the last quarter. West Tower Group LLC purchased a new stake in Doximity during the third quarter valued at approximately $174,000. Harvest Fund Management Co. Ltd boosted its stake in Doximity by 197.1% in the third quarter. Harvest Fund Management Co. Ltd now owns 9,020 shares of the company’s stock valued at $393,000 after acquiring an additional 5,984 shares in the last quarter. Finally, Penserra Capital Management LLC purchased a new position in Doximity in the third quarter worth $2,384,000. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.